author-photo

Xavier Roblin

French Institute of Health and Medical Research

7

Papers

9

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-Analysis of 1317 Patients From 14 Studies

2021 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (2)
P398 The early appearance of anti-drug antibodies during the induction phase predicts the clinical response of adalimumab and infliximab in IBD

2020 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification

2020 Digestive Diseases and Sciences
Show All
- Source
- Cite
- Save
Citations (1)
P703 Addition of azathioprine to switch of anti-TNF in patients with IBD in clinical relapse with pharacokinetic failure: A post hoc analysis of a prospective randomised trial using drug-tolerant assay

2020 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
P426 In failure of non-optimised adalimumab (ADA) with therapeutic serum levels, a change in biotherapy class is greater than an intensification of ADA dose in IBD patients

2020 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)